Νικολάτου - Γαλίτη Ουρανία DDS, MSc, DrDent

Ακαδημαϊκές δημοσιεύσεις

• Ourania Nicolatou-Galitis1 & Maria Kouri1 & Erofili Papadopoulou1 & Emmanouil Vardas1 & Dimitra Galiti1 & Joel B. Epstein2 & Sharon Elad3 & Giuseppina Campisi4 & Nikolaos Tsoukalas5 & Kivanc Bektas-Kayhan6 & Winston Tan7 &Jean-Jacques Body8 & Cesar Migliorati9 & Rajesh V. Lalla10 & for the MASCC Bone Study Group.Osteonecrosis of the jaw related to non-antiresorptive medications:a systematic review. Supprotive Care in Cancer.2019;27:383-394
• S.Singer PhD1 | C. Delphin Amdal MD2 | E. Hammerlid MD3 | I. M. Tomaszewska MD4 | J.Castro Silva MD5 | H.Mehanna PhD6 | M. Santos MD7 | J. Inhestern MD8 | C.Brannan9 | N.Yarom DMD10 | A. Fullerton PhD11 | M. Pinto MD12 | J. I. Arraras PhD13 | N.Kiyota MD14 | P.Bonomo MD15 | A. C. Sherman PhD16 | I. Baumann MD17 | R. Galalae MD18 | L. Fernandez Gonzalez MPH19 | O.Nicolatou-Galitis MD20 | Z. Abdel-Hafeez MD21 | J.Raber-Durlacher DDS, PhD22 | C. Schmalz MD23 | P. Zotti PhD24 | A. Boehm MD25 | D.Hofmeister Dipl.-Psych.26 | S. Krejovic Trivic PhD27 | S. Loo MD28 | W.-C.Chie MD29 | K. Bjordal MD30 | B.Brokstad Herlofson DDS, PhD31 | V. Grégoire MD32 | L. Licitra MD33. International validation of the revised European Organization for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV,WILEY2019; 1-13, doi:10.1002/hed.25609
• Nicolatou-Galitis O, Schiødt M, Amaral Mendes R, Ripamonti C, Hope S, Drudge-Coates L, Niepel D, and Van den Wyngaert T. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment Oral Surg Oral Med Oral Pathol Oral Radiol 2018; in print
• Osteonecrosis of the jaw (ONJ) in patients who receive Bone TargetingAgents (BTAs): the power of e-learning. Ourania Nicolatou-Galitis,Cesar Migliorati. ecancer 2018, 12:ed77, https://doi.org/10.3332/ecancer 77
• A multicenter case registry study on medication-related osteonecrosisof the jaw in patients with advanced cancer. Morten Schiodt, Saroj Vadhan-Raj, Mark S. Chambers, Ourania Nicolatou-Galitis, Constantinus Politis,Ruxandra Coropciuc, Stefano Fedele, Danielle Jandial, Jeffrey Zjang, Haijun Ma, Deborah P. Saunders. Supportive Care in Cancer https://doi.org/10.1007/s00520-017-4003-2. ONJ case registry 2017
• Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients with Cachexia. Wheelwright SJ, HopkinsonJ, Darlington A.S, Fitzsimmons D.F, Fayers P, Balstad T.R, Bredart A, Hammerlid E, Kaasa S, Nicolatou-Galitis O. Volume 53, Issue 2, February 2017, Pages 232–242.
• International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Support Care Cancer (2016), Hjermstad MJ, Bergenmar M, Bjordal K, FisherS, Hofmeister D, Montel M, Nicolatou-Galitis O, 24:3915–3924.
• Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidine. Ourania Nicolatou-Galitis1 , Dimitra Galiti2, Maria Moschogianni3, Sotirios Sachanas3, Beatrice J. Edwards4, Cesar A. Migliorati5, Gerassimos Pangalis6, DOI 20517/2394-4722.2016.06
• Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; Doi.org/10.1016/j.oooo.2015.08.007.
• Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III. Singer S, Arraras JI, Baumann I, Boehm A, Herlofson BB, Silva JC, Chie WC, Fisher S, Guntinas-Lichius O, Hammerlid E, Irarrazaval ME, Hjermstad MJ, Jensen K, Liyota N, Licitra L, Nicolatou-Galitis O, et al. Head & Neck 2015;37:1358-1367.
• Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukemia. Report of a case and literature review. Nicolatou-Galitis O, Sachanas S, Drogari-Apiranthitou M, Moschogiannis M, Galiti D, Yiakoumis X, Rontogianni D, Yiotakis I, Petrikkos G, Pangalis G. J Medical Microbiology Case Reports, 2015;2. Doi:10.1099/jmmcr.0.000014.
• Dental extractions as the major local risk factor of bisphopshonates related jaw osteonecrosis in cancer patients receiving intravenous bsphopshonates therapy. Vardas E, Coward T, Papadopoulou E, Nicolatou-Galitis O. Mediterranean Oncology Journal-MOJ 2014;1:26-33.
• Stomatitis, gingivitis and periodontal abscess in a patient with metastatic renal cell carcinoma receiving temsirolimus and bevacizumab: A cumulative toxicity? Nicolatou-Galitis O, Koutsoukos KA, Galitis E, Bamias A, Dimopoulos MA. Mediterranean Oncology Journal-MOJ 2014;1:45-49.
• MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. Cancer 2014;120:1453-1461.
• International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F. Qual Life Res 2014;23:825-836.
• Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib. A case report with clinical implications. Nicolatou-Galitis O, Razis E, Galiti D, Vardas E, Tzerbos F, Labropoulos S. Forum of Clinical Oncology 2013;4:29-33.
• Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE< Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Support Care Cancer 2013;21:3179-3189.
• Oral ulcers in patients with advanced breast cancer receiving everolimus: Clinical presentation and management. Nicolatou-Galitis O, Nikolaidi A, Athanassiadis I, Papadopoulou E, Sonis S. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:e110-e116.
• Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmaltz C, Verdonck-de Leeuw I, Gamper E, Keszte J, Hofmeister D. Qual Life Research 2013;22:1927-1941.
• Systematic review of amifostine for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Support Care Cancer 2013;21:357-364.
• Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy-Update of the EORTC QLQ-H&N35, Phase I. Singer S, Arraras JI, Bauman I, Boehm A, Chie WC, Galalae R, Langendijk JA, Guntinas-Lichius O, Hammerlid E, Pinto M, Nicolatou-Galitis O, Schmalz C, Sen M, Sherman AC, Spiegel K, Verdonck-de Leew I, Yarom N, Zotti P, Hofmeister D. Head & Neck 2013;35:1331-1338.
• Oral ulcers in cancer patients who receive mTOR inhibitors: an emerging oral toxicity. Nicolatou-Galitis O, Bafaloukos D, Manolakis G, Panayiotidis P, Vardas E, Galiti D, Linardou E. Mediterranean Oncology Journal – MOJ 2012;2:45-51.
• The EORTC QLQ-OH17: A supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, et al. European J of Cancer 2012;48:2203-2211.
• Gingival bleeding in a patient with cervical cancer receiving bevacizumab. Report of a case. Papadopoulou E, Bafaloukos D, Linardou E, Gatou E, Sarri T, Vardas E, Nicolatou-Galitis O. Mediterranean Oncology Journal MOJ 2012;2:54-56.
• Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group. Efficace F, Breccia M, Saussele S, Kossak-Roth U, Cardoni A, Caocci G, Chie W, Naeem A, Nicolatou-Galitis O, et al. Ann Hematol 2012;91:1371-1381.
• Jaw osteonecrosis associated with medication: Report of two cases addressing unresolved clinical research questions. Nicolatou-Galitis O, Bafaloukos D, Razis E, Papadopoulou E, Linardou E, Grossi I, Vardas E, Migliorati CA. Mediterranean Oncology Journal MOJ 2012;2:45-51.
• Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications. Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:234-238.
• Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a Dental Oncology referral Center. Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 112:195-202.
• Oral lichenoid eruption in a patient with chronic myeloid leukemia receiving imatinib. Case report and clinical implications. Nicolatou-Galitis O, Gatou E, Papadopoulou E, Papadaki I, Fisfis M. Mediterranean Oncology Journal MOJ. 2011;1:25-29.
• Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy. Nicolatou-Galitis O, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Athanassiadou P, Kolitsi G, Kouvaris J. Open Cancer Journal 2011;4:7-17.
• A systematic review of oral fungal infections in patients receiving cancer therapy. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D’Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, et al. Support Care Cancer 2010;18:985-992.
• Oral mucositis, pain and xerostomia in patients with head and neck cancer who received chemoradiotherapy with or without cetuximab. Nicolatou-Galitis O, Sarri T, Dardoufas K, Kouloulias V, Vakalis X, et al. Open Clinical Cancer Journal 2010;4:6-14.
• Granulomatous cheilitis associated with exacerbations of Crohn;s disease: a case report. Triantafillidis JK, Zervou-Valvi F, Merikas E, Peros G, Nicolatou-Galitis O, et al. Medical Case Reports, BioMed Central 2008;2:60.
• Oral osteonecrosis associated with the use of ibandronic acid: report of case and clinical implications. Migliorati C, Armonis B, Nicolatou-Galitis O. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008;106:e18-e21.
• Osteonecrosis of the jaw in a patient treated with ibandronate. Vomvas D, Vassiliou V, Papavasileiou D, Kalogeropoulou C, Nicolatou-Galitis O, Kardamakis D.J BUON 2008;13:441-443.
• Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Xanthinaki A, Nicolatou- Galitis O, athanassiadou P, Gonidi M, Kouloulias V, Sotiropoulou-Lontou A, Pissakas G, Kyprianou K, Kouvaris J, Patsouris E. Support Care Cancer 2008;16:1025-1033.
• Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Panos G, karveli EA, Nikolatou O, Falagas ME. Am J Hematology 2007;82:761-765.
• Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, Dardoufas K, Kouloulias V, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou VS, Kouvaris J. Support Care Cancer 2006a; 14:44-51.
• Herpes simplex virus-1 (HSV-1) infection in radiaton-induced oral mucositis. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Gonidi M, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou IS, Kouvaris J. Support Care Cancer 2006b;14:753-762.
• Silent sinus syndrome, a case presentation. Yiotakis I, Papanikolaou V, Alatzidou Z, Manolopoulos L, Nikolatou-Galiti O, Ferekidis E. Rhinology 2005;43:313-315.
• Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Nicolatou-Galitis O, et al. Oral Diseases, 2004, 10:145-150.
• Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A, Pissakas G, Kolitsi G, Kyrpianou K, Kouloulias V, Papanikolaou I, Yiotakis I, Dardoufas K. Oral Oncology 2003;39:397-401.
• Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyrpianou K, Kolitsi G, Pissakas G, Skarleas C, Kouloulias V, Papanicolaou V, Legakis NJ, Velegraki A. J Oral Pathol Med 2001;30:471-480.
• Gingival overgrowth as initial paraneoplastic manifestation of Hodgkin’s lymphoma in a child. Nicolatou-Galitis O, Papadaki T, Moshovi M, Kamma J, Van Vliet-Konstantinidou C, Tzoumakas K, Kattamis A, Tzortzatou-Stathopoulou F. J Periodontology 2001,72:107-112.
• The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow tanslant recipients. Nicolatou-Galitis O, Kitra V, Constantinidou C, Peristeri J, Goussetis E, Petropoulos D, Grafakos S. J Oral Pathol Med 2001;30:148-153.
• Progress of ossification and epithelization of wounds after simple or surgical extractions of teeth in rats with chronic renal failure: an experimental study. Mylonas AI, Massoulas G, Nicolatou O, et al. Br J Oral Maxillofac Surg 2000; 38:34-43.
• Oral hairy leukoplakia in a patient with acute lymphocytic leukemia. Nicolatou O, Nikolatos G, Fisfis M, et al. Oral Dis 1999; 5:76-79.
• Oral lesions in children with perinatally acquired human immunodeficiency virus infection. Nicolatou O, et al. J Oral Pathol Med 1999;28:49-53.
• Paediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis? Velegraki A, Nicolatou O, et al. J Oral Pathol Med 1999;28:178-182.
• A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report. Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, Kyrpianou K, Kolitsi G, Dardoufas K. Int J Radiation Oncology Biol Phys 1998;42:551-556.
• Glossodynia: Personality characteristics and psychopathology. Trikkas G, Nikolatou O, et al. Psychother Psychosom 1996;65:163-168.
• Verruciform xanthoma of the palate: Case report with electron microscopy. Kakarantza-Angelopoulou E, Nicolatou O, et al. J Oral Maxillofac Surg 1991;49:409-412.
• Odontogenic keratocysts: Clinicopathologic study of 87 cases. Kakarantza-Angelopoulou E, Nicolatou O. J Oral Maxillofac Surg 1990;48:593-599.
• Oral spindle cell lipoma. Report of a case. Christopoulos P, Nicolatou O, et al. Int J Oral Maxillofac Surg 1989; 18:208-209.
• Polymorphous low-grade adenocarcinoma of the palate: Report of a case with electron microscopy. Nicolatou O, et al. J Oral Maxillofac Surg 1988;46:1008-1013.
• Correlation of clinical and histological findings of oral tumors. Pierrakou ED, Angelopoulos AP, Nicolatou O. J Oral Med 1986;41:178-183.
• Morphologic changes in rat parotid following isoproterenol administration and fractionated X-irradiation. Nicolatou O. J Oral Pathol Med 1981;10:311-321.
• Ultrastructural characterization of intermediate cells of mucoepidermoid carcinoma of the parotid. Nicolatou O, et al. Oral Surg Oral Med Oral Pathol 1979; 48:324-336.